Literature DB >> 27443133

Classification of Pulmonary Hypertension.

Ronald J Oudiz1.   

Abstract

The classification of pulmonary hypertension (PH) is an attempt to define subtypes of PH based on clinical presentation, underlying physiology, and treatment implications. Five groups of PH have been defined, and the classification scheme has been refined over the years to guide clinicians in the diagnosis and management of PH. Understanding the classification of PH is paramount before embarking on a work-up of patients with PH or suspected PH because treatment and outcome can vary greatly.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Pulmonary hypertension; WHO Group

Mesh:

Year:  2016        PMID: 27443133     DOI: 10.1016/j.ccl.2016.04.009

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  6 in total

1.  Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.

Authors:  Morgan E Whitaker; Vineet Nair; Shripad Sinari; Parinita A Dherange; Balaji Natarajan; Lindsey Trutter; Evan L Brittain; Anna R Hemnes; Eric D Austin; Kumar Patel; Stephen M Black; Joe G N Garcia; Jason X Yuan Md PhD; Rebecca R Vanderpool; Franz Rischard; Ayako Makino; Edward J Bedrick; Ankit A Desai
Journal:  Am J Med       Date:  2018-02-05       Impact factor: 4.965

2.  Hypoxia induces pulmonary arterial fibroblast proliferation, migration, differentiation and vascular remodeling via the PI3K/Akt/p70S6K signaling pathway.

Authors:  Xiaoyu Chai; Dan Sun; Qian Han; Liang Yi; Yanping Wu; Xinmin Liu
Journal:  Int J Mol Med       Date:  2018-02-06       Impact factor: 4.101

3.  rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.

Authors:  Anandharajan Rathinasabapathy; Andrew J Bryant; Toshio Suzuki; Christy Moore; Sheila Shay; Santhi Gladson; James D West; Erica J Carrier
Journal:  Front Physiol       Date:  2018-04-09       Impact factor: 4.566

4.  Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China.

Authors:  Xiufang Kong; Lili Ma; Peng Lv; Xiaomeng Cui; Rongyi Chen; Zongfei Ji; Huiyong Chen; Jiang Lin; Lindi Jiang
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

5.  Src and Epidermal Growth Factor Receptor: Novel Partners in Mediating Chronic Hypoxia-induced Pulmonary Artery Hypertension.

Authors:  Yuansheng Gao; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

6.  A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease.

Authors:  Simon Bax; Charlene Bredy; Aleksander Kempny; Konstantinos Dimopoulos; Anand Devaraj; Simon Walsh; Joseph Jacob; Arjun Nair; Maria Kokosi; Gregory Keir; Vasileios Kouranos; Peter M George; Colm McCabe; Michael Wilde; Athol Wells; Wei Li; Stephen John Wort; Laura C Price
Journal:  ERJ Open Res       Date:  2018-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.